Neurocognitive Disorders: From Risk Factors to Treatment

9/1/2025 | 8:00 PM CDT

1.25 On-Demand

Intermediate

$500

Jack CR, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimer's Dement. 2024;20:5143–5169.
Arslan B, Zetterberg H, Ashton NJ. Blood-based biomarkers in Alzheimer's disease - moving towards a new era of diagnostics. Clin Chem Lab Med. 2024;62(6):1063-1069. doi:10.1515/cclm-2023-1434.
Sims JR, et al. Donanemab Associated with Decreased Amyloid Burden and Slower Cognitive Decline. JAMA. 2023;330(6):512-527.